MedPath

A comparison of the efficacy of concurrent use of intracervical foley catheter balloon and mifepristone to intracervical foley catheter alone for cervical ripening at term: a triple-blind randomized control trial

Not Applicable
Conditions
Pregnancy and Childbirth
Registration Number
PACTR202306488956692
Lead Sponsor
ESE ADIGBA ONODJOHWOYOVWE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
112
Inclusion Criteria

All Consented pregnant women with the following:
1.Term pregnancy
2. Singleton foetus in cephalic presentation
3.Intact foetal membrane
4.Normal non stress test
5.Bishop Score of < 6
6.No contraindication to vaginal delivery
7.No known allergy or contraindication to Mifepristone.

Exclusion Criteria

1. Preterm pregnancy
2. Prolonged pregnancy (=42 weeks gestation)
3. Prelabour rupture of foetal membrane
4. Previous caesarean section or major uterine surgery
5. Bishop score = 6 at admission
6. Foetal malpresentation
7. Multiple pregnancy
8. Intrauterine foetal death,
9. Severe intrauterine growth restriction
10. Severe oligohydramnios
11. Major congenital anomalies
12. Allergy or contraindication to use of Mifepristone
13. Abnormal or non-reassuring non stress test
14. Contraindication to vaginal delivery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath